Photo of Thenappan Thenappan
Contact Expert

View Scopus Profile

Thenappan Thenappan

 https://orcid.org/0000-0002-6210-0467
20072023

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research interests

Pulmonary vascualr disease and right ventricular dysfunction. Currently studying the safety and efficacy of beta-blockers in the treatment of right ventricualr dysfunction due to pulmonary arterial hypertension.

Personal profile

Thenappan Thenappan is an Assisatnt Professor in the Department of Medicine at the University of Minnesota. Minneapolis, MN. He is a memeber of American Heart Association, American Thoracic Society, International Society of Heart and Lung Transplant, Pulmonary Vascualr Research Institute, and Pulmonary Hypertension Association. He has published on pulmonary vascualr disease and right ventricuar dysfunction in high impact factor journals including Circulation, Circulation Heart Failure, Journal of American College of Cardiology, American Journal of Respiratory and Critical Care Medicine, European Respiratory Journal, and Chest.

Research interests

  • Pulmonary vascualr disease
  • Right ventricular dysfunction
  • Right heart failure

Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.

  • 2 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

A Double-Blind, Randomized, Placebo-Controlled Study of Levosimendan in Pulmonary HypertensionPatients with Heart Failure and Preserved Left Ventricular Ejection Fraction (PHHFpEF)

Thenappan, T.

TENAX THERAPEUTICS, INC

4/1/19 → 4/30/23

Project: Research project

    • An Open-Label Rollover Study of Levosimendan in Patients with Pulmonary Hypertensionwith Heart Failure and Preserved Left Ventricular Ejection Fraction (PH-HFpEF)

    Thenappan, T.

    TENAX THERAPEUTICS, INC

    4/1/19 → 4/30/23

    Project: Research project

    • An Open-Label Extension Study of Inhaled Treprostinil in

    Thenappan, T.

    United Therapeutics Corporation

    10/1/16 → 10/30/21

    Project: Research project

    • A Multi-Center Randomized double blind placebo controlle

    Thenappan, T.

    United Therapeutics Corporation

    10/1/16 → 10/30/21

    Project: Research project

    • An Open-label Extension Study of Oral Treprostinil in Su

    Thenappan, T.

    United Therapeutics Corporation

    10/1/17 → 11/14/19

    Project: Research project

    • Research Output

    Hypochloremia Is a Noninvasive Predictor of Mortality in Pulmonary Arterial Hypertension

    Prins, K. W., Kalra, R., Rose, L., Assad, T. R., Archer, S. L., Bajaj, N. S., Weir, E. K., Prisco, S. Z., Pritzker, M., Lutsey, P. L., Brittain, E. L. & Thenappan, T., Mar 3 2020, In : Journal of the American Heart Association. 9, 5, p. e015221

    Research output: Contribution to journal › Article

    Open Access

    • Association between angiotensin II antagonism and gastrointestinal bleeding on left ventricular assist device support

    Schultz, J., John, R., Alexy, T., Thenappan, T. & Cogswell, R., Apr 2019, In : Journal of Heart and Lung Transplantation. 38, 4, p. 469-471 3 p.

    Research output: Contribution to journal › Letter

    1 Scopus citations

    Can intestinal microbiota and circulating microbial products contribute to pulmonary arterial hypertension?

    Thenappan, T., Khoruts, A., Chen, Y. & Weir, E. K., Nov 1 2019, In : American journal of physiology. Heart and circulatory physiology. 317, 5, p. H1093-H1101

    Research output: Contribution to journal › Article

    • 1 Scopus citations

    Clinical determinants and prognostic implications of right ventricular dysfunction in pulmonary hypertension caused by chronic lung disease

    Prins, K. W., Rose, L., Archer, S. L., Pritzker, M. R., Weir, E. K., Olson, M. D. & Thenappan, T., Jan 1 2019, In : Journal of the American Heart Association. 8, 2, e011464.

    Research output: Contribution to journal › Article

    • 2 Scopus citations

    Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysis

    UK NIHR BioResource Rare Diseases Consortium, UK PAH Cohort Study Consortium & US PAH Biobank Consortium, Mar 2019, In : The Lancet Respiratory Medicine. 7, 3, p. 227-238 12 p.

    Research output: Contribution to journal › Article

    Open Access
    • 10 Scopus citations